|
PEN1 |
|
BUDGET-IMPACT OF THYROIDS
DISEASE IN GERMANY
Vauth C, University of Hanover, Hanover,
Germany, Greiner W, Bielefeld University,
Bielefeld, Germany
OBJECTIVE:
To determine the disease related costs
of thyroids dysfunction in Germany from a payer
and social perspective with regard to thyroid
induced cardial arrhythmia. METHODS:
Retrospective
analysis of a german compulsory health insurance
between January 2000 und December 2002.
Identification of thyroid patients via ICD-10
diagnosis and typical thyroid pharmaceuticals.
Included costs: outpatient care, inpatient care,
pharmaceuticals, indirect costs as productivity
losses. RESULTS:
115,399 up to 116,262 thyroid
patients have been identified and analysed. Using
database prevalence to extrapolate the findings to
the german population this results in 1.28 up to
1.37 billion EURO direct costs and 167 up to 182
million EURO indirect costs per year. CONLUSIONS:
Approximately 1% of german compulsory health
insurance expenditures have to be spend on
thyroids disease. Thus, new economic evaluations
of primary prevention programs or the
cost-effectiveness of pharmaceuticals used are
requested. |
|
